Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idarubicin and High-Dose Cytarabine in Adult Acute Myeloid Leukemia
NCT00528398Phase 2Completed
- Sponsor
- City of Hope
- Start
- Sep 1994
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of idarubicin, cytarabine in acute myeloid leukemia (AML), sponsored by City of Hope. Started Sep 1994; status: completed.
02
Drugs
idarubicincytarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00528398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00528398.